首页> 外文期刊>Bone marrow transplantation >Automated measurement of schistocytes after bone marrow transplantation.
【24h】

Automated measurement of schistocytes after bone marrow transplantation.

机译:骨髓移植后血细胞的自动测量。

获取原文
获取原文并翻译 | 示例
       

摘要

Bone marrow transplantation-related thrombotic microangiopathy (BMT-TMA) is a severe complication partly suspected on the evidence of a microangiopathic haemolysis. Microscopic schistocyte observation confirms the mechanical origin of the haemolysis, but remains a tedious procedure that lacks standardization. Direct measurement of abnormal red blood cell (RBC) fragments is now available on some automated haematology systems. We compared in 131 patients (69 BMT with five BMT-TMA, 38 thrombotic thrombocytopenic syndromes, 11 macroangiopathies, 13 dyserythropoiesis) percentages of microscopic schistocytes and automated RBC fragments (Bayer ADVIA 120) to evaluate the clinical relevance of the automated measurements for BMT-TMA detection. The analyser correlated well with the microscope (intraclass correlation coefficient: 0.82) and quantified RBC fragments with a moderate overestimation (+0.4%) as compared to microscopic counts. BMT patients had higher RBC fragments when they had TMA (1.1 vs 0.4% without TMA). Automated counting was useful to flag BMT-related TMA, particularly when RBC fragments were above 1%. As RBC fragments were frequently detected in BMT patients even without TMA, a threshold of less 1% that ruled out TMA was determined with a 98% negative predictive value. The new RBC fragment automated parameter proved its clinical value to assess BMT-TMA, which might be useful for day-to-day monitoring of the post BMT period.
机译:骨髓移植相关的血栓性微血管病(BMT-TMA)是一种严重的并发症,部分被怀疑是微血管性溶血的证据。显微血细胞观察证实了溶血的机械起源,但仍然是乏味的过程,缺乏标准化。现在,在某些自动化血液学系统上可以直接测量异常红细胞(RBC)片段。我们比较了131例患者(69例BMT伴有5例BMT-TMA,38例血栓性血小板减少综合征,11例大血管病变,13例促红细胞减少症)的显微血吸虫细胞和自动RB​​C片段(Bayer ADVIA 120)的百分比,以评估BMT-自动检测的临床意义TMA检测。与显微镜相比,分析仪与显微镜的相关性很好(类内相关系数:0.82),并且定量的RBC片段具有适度的高估(+ 0.4%)。 BMT患者在接受TMA时具有更高的RBC碎片(1.1对0.4%,而无TMA)。自动计数有助于标记与BMT相关的TMA,尤其是当RBC片段高于1%时。由于即使在没有TMA的情况下,在BMT患者中也经常检测到RBC片段,因此将排除TMA的阈值确定为小于1%的阈值为98%的阴性预测值。新的RBC片段自动化参数证明了其评估BMT-TMA的临床价值,这可能对BMT期后的日常监测有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号